No profile data available.
60 Degrees Pharmaceuticals, Inc. (SXTP) is a healthcare company in the additional infection treatment pharmaceuticals industry, based in Washington, United States, with about 3 full-time employees.
It reported revenue of $1.01 million for fiscal year 2025, up 65.5% from fiscal year 2024, and net income of -$7.37 million. Its market capitalization was $3.40 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.
60 Degrees Pharmaceuticals reported $1.01 million in revenue for fiscal year 2025, up 65.5% from $607,574 in fiscal year 2024.
$3.40 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional infection treatment pharmaceuticals) include Scynexis, Inc. (SCYX), Daré Bioscience, Inc. (DARE), Pulmatrix, Inc. (PULM), Matinas BioPharma Holdings, Inc. (MTNB).